Bristol Myers Squibb BMY
NYSE BMY
$63.01 +1.86 (+3.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) reported Depreciation & Amortization (CF) of $594 million for Q2 2026, down 41.2% from $1.01 billion a year earlier and unchanged from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Bristol Myers Squibb's Depreciation & Amortization (CF) came in at $3.18 billion, down 51.1% year-over-year; for FY2025, it came in at $4.01 billion, down 58.2% from FY2024.

  • Depreciation & Amortization (CF) has declined for four consecutive years, with a five-year compound annual growth rate of -17.3% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $9.6 billion in FY2024 (-1.6%), $9.76 billion in FY2023 (-5.0%), $10.28 billion in FY2022 (-3.8%) and $10.69 billion in FY2021 (+2.9%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $594 million in Q1 2026 and a high of $2.73 billion in Q3 2021.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last seven quarters, with an average decline of 41.2% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2024 (growth of 6.7%); the low point was Q2 2025 (a decline of 61.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $594 million (Q1 2026), $977 million (Q4 2025) and $1.01 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 2.12 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 194.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 1.93 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 1.62 Bn
10 Bristol Myers Squibb 125.50 Bn 76.77 Bn 9.25 Bn 594.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 594.00 Mn
Mar 31, 2026 594.00 Mn
Dec 31, 2025 977.00 Mn
Sep 30, 2025 1.01 Bn
Jun 30, 2025 1.01 Bn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 1.88 Bn
Sep 30, 2024 2.59 Bn
Jun 30, 2024 2.60 Bn
Mar 31, 2024 2.53 Bn
Dec 31, 2023 2.46 Bn
Sep 30, 2023 2.44 Bn
Jun 30, 2023 2.43 Bn
Mar 31, 2023 2.43 Bn
Dec 31, 2022 2.52 Bn
Sep 30, 2022 2.59 Bn
Jun 30, 2022 2.58 Bn
Mar 31, 2022 2.58 Bn
Dec 31, 2021 2.58 Bn
Sep 30, 2021 2.73 Bn
API Access

Bristol Myers Squibb Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BMY&period=max&api_key=YOUR_API_KEY